1-13 of 13
Jason C. Chandler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Fresh Versus Cryopreserved Peripheral Stem Cell for Autologous Transplantation in Multiple Myeloma: An Analysis of Short-Term Outcomes

Jacinth Joseph, MD, Vanessa Wookey, MD, Brion Randolph, MD, Jason C. Chandler, MD, Dennis Marjoncu, PharmD, BCOP, Kori Holman, PharmD, Deniscer Peeler, LPN, Michelle Armstrong, NP, Yasser Khaled, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 9–10.
https://doi.org/10.1182/blood-2020-143049
Published: 2020
Journal Articles

Early Immune Reconstitution after Haplo-Identical Hematopoietic Stem Cell Transplantation (HCT) with Post-Transplant Cyclophosphamide (PTCY) Does Not Improve Overall Survival Compared to Matched Unrelated Donor HCT Recipients Receiving Thymoglobulin Prophylaxis (ATG)

Yasser Khaled, MD, Joshua Boss, RN, OCN, BMTCN, Poojitha Valasareddy, MD, Arnel Pallera, MD, Robert Johnson, MD, Deniscer Peeler, LPN, Jason C. Chandler, MD, Joel Gradowski, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5676.
https://doi.org/10.1182/blood-2019-131954
Published: 2019
Journal Articles

Improved Relapse Rate, T Cell Recovery and Engraftment in High Risk Hematological Malignancies with Enhanced Lympho-Depletion Prior to T-Cell Replete Peripheral Blood Haploidentical (HID) Hematopoietic Stem Cell Transplantation (HCT)

Yasser Khaled, MD, Joshua Boss, RN, OCN, BMTCN, Joel Gradowski, MD, Robert Bradley, MD, Jason C. Chandler, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2117.
https://doi.org/10.1182/blood-2018-99-115290
Published: 2018
Journal Articles

T-Cell Replete Peripheral Blood Haploidentical Transplant Using Immunogenic Dose of Cyclophosphamide with Fludarabine and Melphalan Results in Enhanced Cytokine Release Syndrome (CRS) with Robust Immune Recovery and Low Relapse Rates

Yasser Khaled, MD, Jason C. Chandler, MD, Joshua Boss, RN, OCN, Arnel Pallera, MD, Michael G. Martin, MD, Robert Bradley, MD, Robert Johnson, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1934.
https://doi.org/10.1182/blood.V130.Suppl_1.1934.1934
Published: 2017
Journal Articles

CC-122 DLBCL-001: Phase Ib Study of CC-122 Plus Rituximab in Patients with Chemo-Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Vincent Ribrag, Julio C. Chavez, MD, Umberto Vitolo, MD, Jason B. Kaplan, MD, Jason C. Chandler, MD, Armando Santoro, MD, Paolo Corradini, MD, Ian W. Flinn, MD PhD, Loretta Nastoupil, MD, Philippe A. Cassier, MD, Randeep Sangha, MD, Vaishalee P. Kenkre, MD, Ranjana H. Advani, MD, Iris Isufi, MD, Thomas E Witzig, MD, Michael Petrarca, PhD, Patrick R. Hagner, PhD, Anita K. Gandhi, PhD, Xiaoling Wu, PhD, Kristen Hege, MD, Michael Pourdehnad, MD, John Kuruvilla, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1551.
https://doi.org/10.1182/blood.V130.Suppl_1.1551.1551
Published: 2017
Journal Articles

A Phase 1b, Multi-Center, Open-Label Study of Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-Cell Lymphoma: CC-122-DLBCL-001

Vincent Ribrag, MD, Julio C. Chavez, MD, Jason B Kaplan, MD, Umberto Vitolo, MD, Jason C. Chandler, MD, Armando Santoro, MD, Paolo Corradini, MD, Philippe Cassier, MD, Ian W. Flinn, MD PhD, Ranjana Advani, MD, Randeep Sangha, Iris Isufi, MD, Vaishalee P. Kenkre, MD, Patrick R. Hagner, Torsten Trowe, PhD, Anita K. Gandhi, PhD, Xiaoling Wu, PhD, Kristen Hege, MD, Michael Pourdehnad, John Kuruvilla, MD
Journal: Blood
Blood (2016) 128 (22): 1849.
https://doi.org/10.1182/blood.V128.22.1849.1849
Published: 2016
Journal Articles

The Addition of Rituximab to Chemotherapy Decreased Rates of Primary Surgery for Gastric Diffuse Large B-Cell Lymphoma without Increasing Early Mortality

Eric Wiedower, DO, Smith Giri, MBBS, Andrew Fintel, DO, Philip Prouet, MD, Elena Paulus, MD, Jason C. Chandler, MD, Mike G. Martin, MD
Journal: Blood
Blood (2015) 126 (23): 4475.
https://doi.org/10.1182/blood.V126.23.4475.4475
Published: 2015
Journal Articles

Comorbidities Drive Outcomes for Both Malignancy and Non-Malignancy Associated Hemophagocytic Syndrome

Benny Johnson, DO, Smith Giri, MBBS, Sara E. Nunnery, Eric Wiedower, DO, Omer Jamy, MD, Jason C. Chandler, MD, Mike G. Martin, MD
Journal: Blood
Blood (2015) 126 (23): 3261.
https://doi.org/10.1182/blood.V126.23.3261.3261
Published: 2015
Journal Articles

Single Cell Network Profiling as a Platform to Reveal Leukemia-Specific Signaling Signatures and Sensitivity to Kinase Inhibitor Therapies

Todd M. Covey, Michael Gulrajani, Heiko Becker, MD, Jason C. Chandler, MD, Sebastian Schwind, MD, Guido Marcucci, MD, Alessandra Cesano, MD
Journal: Blood
Blood (2010) 116 (21): 2753.
https://doi.org/10.1182/blood.V116.21.2753.2753
Published: 2010
Journal Articles

Interleukin-15 Is a Proto-Oncogene In Acute Large Granular Lymphocyte Leukemia

Anjali Mishra, Ph.D., Shujun Liu, Ph.D., Gregory H Sams, Douglas P Curphey, Ramasamy Santhanam, PhD, Laura J Rush, DVM, PhD, Deanna Schaefer, DVM, Lauren G Falkenberg, Laura Sullivan, Laura Jaroncyk, Xunchang Zou, MS, Harold Fisk, PhD, Jadwiga Labanowska, MS, Enrico Caserta, PhD, Lai-Chu Wu, MD, PhD, Heiko Becker, MD, Sebastian Schwind, MD, Jason C. Chandler, MD, Yue-Zhong Wu, MS, Nyla A. Heerema, Ph.D., Pierluigi Porcu, MD, Ramiro Garzon, MD, Guido Marcucci, MD, Michael A. Caligiuri, MD
Journal: Blood
Blood (2010) 116 (21): 704.
https://doi.org/10.1182/blood.V116.21.704.704
Published: 2010
Journal Articles

Effective Targeting of Acute Myeloid Leukemia (AML) Harboring the FLT3 ITD Mutation through the Axl/Gas6 Pathway

Il-Kyoo Park, Anjali Mishra, Jason C. Chandler, Michael A. Caligiuri
Journal: Blood
Blood (2010) 116 (21): 500.
https://doi.org/10.1182/blood.V116.21.500.500
Published: 2010
Journal Articles

Suppression of RISC-Independent Decoy and RISC-Mediated mRNA Base-Pairing Activities of MicroRNA-328 Is Required for Differentiation-Arrest and Enhanced Survival of Blast Crisis CML Progenitors.

Anna M Eiring, PhD, Jason Harb, PhD, Paolo Neviani, PhD, Joshua Oaks, BS, Shujun Liu, PhD, Riccardo Spizzo, Sebastian Schwind, MD, Ramasamy Santhanam, PhD, Christopher Hickey, MS, Heiko Becker, MD, Jason C. Chandler, MD, Raul Andino, PhD, Jorge Cortes, MD, Peter Hokland, Sr., M.D., D., Med., Sci., Claudia Huettner, PhD, Ravi Bhatia, MD, Denis-Claude Roy, MD, Stephen Liebhaber, MD, Michael A. Caligiuri, M.D., Guido Marcucci, MD, Ramiro Garzon, MD, Carlo M. Croce, MD, George A Calin, MD, PhD, Danilo Perrotti, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 855.
https://doi.org/10.1182/blood.V114.22.855.855
Published: 2009
Journal Articles

Phase I Study of Lenalidomide in Acute Leukemia: Remissions in Post-Allogeneic Relapse of Acute Myeloid Leukemia.

Jason C. Chandler, MD, Rebecca B. Klisovic, MD, Mitch A. Phelps, PhD, Alison Walker, MD, Ramiro Garzon, MD, Xiaoxia Yang, Larry Schaaf, PhD, Sebastian Schwind, MD, Heiko Becker, MD, Shujun Liu, PhD, Chris Hickey, Cheryl Kefauver, RN, Jon Mickle, CNP, Steven M Devine, MD, Michael R. Grever, MD, John C. Byrd, MD, Guido Marcucci, MD, William Blum, MD
Journal: Blood
Blood (2009) 114 (22): 841.
https://doi.org/10.1182/blood.V114.22.841.841
Published: 2009